Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Alzheimer's Disease

  Free Subscription


3 Acta Neuropathol
7 Alzheimers Dement
1 BMC Geriatr
2 Brain
1 Brain Res
1 Curr Alzheimer Res
1 Exp Gerontol
1 Int J Neurosci
11 J Alzheimers Dis
3 J Biol Chem
3 J Neurochem
1 J Neurosci
1 Nat Rev Neurol
1 Nature
1 Nervenarzt
4 Neurobiol Aging
1 Neurobiol Dis
1 Neurol Clin Pract
5 Neurology
1 Neuropsychology
1 Neurosci Lett
1 Neuroscience
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Neuropathol

  1. CHUNG M, Carter EK, Veire AM, Dammer EB, et al
    Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains.
    Acta Neuropathol. 2024;147:29.
    PubMed         Abstract available

  2. OERTEL FC, Casillas D, Cobigo Y, Condor Montes S, et al
    Scientific commentary on: "Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies".
    Acta Neuropathol. 2024;147:30.

  3. COLOM-CADENA M, Toombs J, Simzer E, Holt K, et al
    Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's disease.
    Acta Neuropathol. 2024;147:32.
    PubMed         Abstract available

    Alzheimers Dement

  4. BELLOMO G, Toja A, Paolini Paoletti F, Ma Y, et al
    Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay.
    Alzheimers Dement. 2024 Feb 7. doi: 10.1002/alz.13658.
    PubMed         Abstract available

  5. BELLOMO G, Bayoumy S, Megaro A, Toja A, et al
    Fully automated measurement of plasma Abeta42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts.
    Alzheimers Dement. 2024 Feb 7. doi: 10.1002/alz.13687.
    PubMed         Abstract available

  6. ZHONG H, Zhou X, Uhm H, Jiang Y, et al
    Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification.
    Alzheimers Dement. 2024 Feb 7. doi: 10.1002/alz.13691.
    PubMed         Abstract available

  7. ABADIR P, Oh E, Chellappa R, Choudhry N, et al
    Artificial Intelligence and Technology Collaboratories: Innovating aging research and Alzheimer's care.
    Alzheimers Dement. 2024 Feb 7. doi: 10.1002/alz.13710.
    PubMed         Abstract available

  8. TAHA HB
    Early detection of subjective cognitive decline and Alzheimer's disease: Analytical validation of a newly developed pT217-tau assay.
    Alzheimers Dement. 2024 Feb 8. doi: 10.1002/alz.13707.

  9. GONZALEZ-ORTIZ F, Karikari TK, Blennow K
    Analytical and clinical validation of Alzheimer's disease blood biomarkers with a focus on plasma p-tau217.
    Alzheimers Dement. 2024 Feb 8. doi: 10.1002/alz.13708.
    PubMed         Abstract available

  10. DIAZ-GALVAN P, Przybelski SA, Algeciras-Schimnich A, Figdore DJ, et al
    Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies.
    Alzheimers Dement. 2024 Feb 8. doi: 10.1002/alz.13653.
    PubMed         Abstract available

    BMC Geriatr

  11. DURRANI S, Ahmed S
    Case report: a unique presentation of memantine overdose causing echolalia and hypertension.
    BMC Geriatr. 2024;24:123.
    PubMed         Abstract available


  12. ALBERT-GASCO H, Smith HL, Alvarez-Castelao B, Swinden D, et al
    Trazodone rescues dysregulated synaptic and mitochondrial nascent proteomes in prion neurodegeneration.
    Brain. 2024;147:649-664.
    PubMed         Abstract available

  13. YANG HS, Yau WW, Carlyle BC, Trombetta BA, et al
    Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.
    Brain. 2024 Feb 5:awae034. doi: 10.1093.
    PubMed         Abstract available

    Brain Res

  14. DHEVII MANOHARAN S, Abdul Hamid H, Fariesha Md Hashim N, Singh Cheema M, et al
    Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer's pathologies?
    Brain Res. 2024 Feb 1:148793. doi: 10.1016/j.brainres.2024.148793.
    PubMed         Abstract available

    Curr Alzheimer Res

  15. GUO Y, Sun CK, Tang L, Tan MS, et al
    Microglia PTK2B/Pyk2 in the Pathogenesis of Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Feb 6. doi: 10.2174/0115672050299004240129051655.
    PubMed         Abstract available

    Exp Gerontol

  16. LIU T, Li N, Pu J, Zhang C, et al
    The plasma derived exosomal miRNA-483-5p/502-5p serve as potential MCI biomarkers in aging.
    Exp Gerontol. 2024;186:112355.
    PubMed         Abstract available

    Int J Neurosci

  17. METKAR SK, Girigoswami A, Bondage DD, Shinde UG, et al
    The potential of lumbrokinase and serratiopeptidase for the degradation of Abeta 1-42 peptide - an in vitro and in silico approach.
    Int J Neurosci. 2024;134:112-123.
    PubMed         Abstract available

    J Alzheimers Dis

  18. PLASSMAN BL, Ford CB, Smith VA, DePasquale N, et al
    Elevated Amyloid-beta PET Scan and Cognitive and Functional Decline in Mild Cognitive Impairment and Dementia of Uncertain Etiology.
    J Alzheimers Dis. 2024;97:1161-1171.
    PubMed         Abstract available

  19. ROBILLARD JM, Masellis M, Martin SE, Khachaturian AS, et al
    The Return of Biomarker Results in Research: Balancing Complexity, Precision, and Ethical Responsibility.
    J Alzheimers Dis. 2024;97:1083-1090.
    PubMed         Abstract available

  20. PANZAVOLTA A, Cerami C, Marcone A, Zamboni M, et al
    Diagnostic Performance of Socio-Emotional Informant-Based Questionnaires for the Clinical Detection of the Behavioral Variant of Frontotemporal Dementia.
    J Alzheimers Dis. 2024;97:1249-1260.
    PubMed         Abstract available

  21. OKAHASHI S, Noguchi T, Ishihara M, Osawa A, et al
    Dyadic Art Appreciation and Self-Expression Program (NCGG-ART) for People with Dementia or Mild Cognitive Impairment and Their Family Caregivers: A Feasibility Study.
    J Alzheimers Dis. 2024;97:1435-1448.
    PubMed         Abstract available

  22. DU P, Zhang X, Lian X, Holscher C, et al
    O-GlcNAcylation and Its Roles in Neurodegenerative Diseases.
    J Alzheimers Dis. 2024;97:1051-1068.
    PubMed         Abstract available

  23. MARIN-MARIN L, Renau-Lagranja J, Avila C, Costumero V, et al
    Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;97:1341-1351.
    PubMed         Abstract available

  24. TSENG YT, Chang YL, Chiu YS
    Assessment of Language Function in Older Mandarin-Speaking Adults with Mild Cognitive Impairment using Multifaceted Language Tests.
    J Alzheimers Dis. 2024;97:1189-1209.
    PubMed         Abstract available

  25. KARAYIANNIS CC, Srikanth V, Beare R, Mehta H, et al
    Type 2 Diabetes and Biomarkers of Brain Structure, Perfusion, Metabolism, and Function in Late Mid-Life: A Multimodal Discordant Twin Study.
    J Alzheimers Dis. 2024;97:1223-1233.
    PubMed         Abstract available

  26. ZAWISLAK-FORNAGIEL K, Ledwon D, Bugdol M, Grazynska A, et al
    Quantitative EEG Spectral and Connectivity Analysis for Cognitive Decline in Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;97:1235-1247.
    PubMed         Abstract available

  27. SHANG L, Dong L, Huang X, Chu S, et al
    Comorbidity of Dementia: A Cross-Sectional Study of PUMCH Dementia Cohort.
    J Alzheimers Dis. 2024;97:1313-1322.
    PubMed         Abstract available

  28. ALEGRET M, Garcia-Gutierrez F, Munoz N, Espinosa A, et al
    FACEmemory(R), an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.
    J Alzheimers Dis. 2024;97:1173-1187.
    PubMed         Abstract available

    J Biol Chem

  29. SERNEELS L, Bammens L, Zwijsen A, Tolia A, et al
    Functional and topological analysis of PSENEN, the fourth subunit of the gamma-secretase complex.
    J Biol Chem. 2024;300:105533.
    PubMed         Abstract available

  30. LACROIX MS, Artikis E, Hitt BD, Beaver JD, et al
    Tau seeding without tauopathy.
    J Biol Chem. 2024;300:105545.
    PubMed         Abstract available

  31. LI Y, Liu D, Zhang X, Rimal S, et al
    RACK1 and IRE1 participate in the translational quality control of amyloid precursor protein in Drosophila models of Alzheimer's disease.
    J Biol Chem. 2024 Feb 2:105719. doi: 10.1016/j.jbc.2024.105719.
    PubMed         Abstract available

    J Neurochem

  32. FERNANDES T, Melo T, Conde T, Neves B, et al
    Mapping the lipidome in mitochondria-associated membranes (MAMs) in an in vitro model of Alzheimer's disease.
    J Neurochem. 2024 Feb 7. doi: 10.1111/jnc.16072.
    PubMed         Abstract available

  33. LIANG Y, Deng MG, Jian Q, Liu M, et al
    Maternal history of Alzheimer's disease predisposes to altered serum cholesterol levels in adult offspring.
    J Neurochem. 2024 Feb 5. doi: 10.1111/jnc.16056.
    PubMed         Abstract available

  34. SU M, Xuan E, Sun X, Pan G, et al
    Synaptic adhesion molecule protocadherin-gammaC5 mediates beta-amyloid-induced neuronal hyperactivity and cognitive deficits in Alzheimer's disease.
    J Neurochem. 2024 Feb 3. doi: 10.1111/jnc.16066.
    PubMed         Abstract available

    J Neurosci

  35. PHILLIPS JS, Robinson JL, Cousins KAQ, Wolk DA, et al
    Polypathologic Associations with Gray Matter Atrophy in Neurodegenerative Disease.
    J Neurosci. 2024;44:e0808232023.
    PubMed         Abstract available


  36. HARRIS E
    Commercial Blood Test May Identify Alzheimer Disease Brain Pathology.
    JAMA. 2024 Feb 7. doi: 10.1001/jama.2024.0175.

    Nat Rev Neurol

  37. WOOD H
    Tau aids selection of anti-amyloid drug recipients.
    Nat Rev Neurol. 2024;20:63.


    Obesity drugs have another superpower: taming inflammation.
    Nature. 2024;626:246.


  39. HAUSSMANN R, Homeyer P, Haussmann M, Sauer C, et al
    [Analysis of the prevalence of anticoagulant therapy in patients with cognitive disorders and cerebral amyloid angiopathy (CAA)].
    Nervenarzt. 2024;95:146-151.
    PubMed         Abstract available

    Neurobiol Aging

  40. TAGHVAEI M, Mechanic-Hamilton DJ, Sadaghiani S, Shakibajahromi B, et al
    Impact of white matter hyperintensities on structural connectivity and cognition in cognitively intact ADNI participants.
    Neurobiol Aging. 2024;135:79-90.
    PubMed         Abstract available

  41. ZHANG YN, Chen XL, Guo LY, Jiang PR, et al
    Downregulation of peripheral luteinizing hormone rescues ovariectomy-associated cognitive deficits in APP/PS1 mice.
    Neurobiol Aging. 2024;135:60-69.
    PubMed         Abstract available

  42. HEMMINGHYTH MS, Chwiszczuk LJ, Breitve MH, Gisladottir B, et al
    Cerebrospinal fluid neurofilament light chain mediates age-associated lower learning and memory in healthy adults.
    Neurobiol Aging. 2024;135:39-47.
    PubMed         Abstract available

  43. BABILONI C, Noce G, Tucci F, Jakhar D, et al
    Poor reactivity of posterior electroencephalographic alpha rhythms during the eyes open condition in patients with dementia due to Parkinson's disease.
    Neurobiol Aging. 2024;135:1-14.
    PubMed         Abstract available

    Neurobiol Dis

  44. KATSUMATA Y, Wu X, Aung KZ, Gauthreaux K, et al
    Pathologic correlates of aging-related tau astrogliopathy: ARTAG is associated with LATE-NC and cerebrovascular pathologies, but not with ADNC.
    Neurobiol Dis. 2024;191:106412.
    PubMed         Abstract available

    Neurol Clin Pract

  45. RAMPALLI I, Pavlik VN, Yu MM, Bishop J, et al
    Cognitive Function Remains Associated With Functional Impairment in Profound Dementia: Alzheimer Disease and Dementia With Lewy Bodies.
    Neurol Clin Pract. 2024;14:e200262.
    PubMed         Abstract available


  46. COUSINS KAQ, Irwin DJ, Tropea TF, Rhodes E, et al
    Evaluation of ATN(PD) Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease.
    Neurology. 2024;102:e208033.
    PubMed         Abstract available

  47. WANG Q, Schindler SE, Chen G, Mckay NS, et al
    Investigating White Matter Neuroinflammation in Alzheimer Disease Using Diffusion-Based Neuroinflammation Imaging.
    Neurology. 2024;102:e208013.
    PubMed         Abstract available

    White Matter Neuroinflammation Matters in Early Alzheimer Disease.
    Neurology. 2024;102:e208090.

  49. ADESUYAN M, Jani YH, Alsugeir D, Howard R, et al
    Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease: A Cohort Study.
    Neurology. 2024;102:e209131.
    PubMed         Abstract available

  50. YASAR S, Nidadavolu L
    Repurposing Erectile Dysfunction Medication for Alzheimer Disease Prevention.
    Neurology. 2024;102:e209180.


  51. GARCIA DL, Gollan TH
    Language switching and speaking a nondominant language challenge executive control: Preliminary data for novel behavioral markers of Alzheimer's risk in Spanish-English bilinguals.
    Neuropsychology. 2024 Feb 8. doi: 10.1037/neu0000943.
    PubMed         Abstract available

    Neurosci Lett

  52. KAAR A, Weir MP, Rae MG
    Altered neuronal group 1 metabotropic glutamate receptor- and endoplasmic reticulum-mediated Ca(2+) signaling in two rodent models of Alzheimer's disease.
    Neurosci Lett. 2024;823:137664.
    PubMed         Abstract available


  53. ZHANG H, Yang Y, Zhang J, Huang L, et al
    Oligodendrocytes Play a Critical Role in White Matter Damage of Vascular Dementia.
    Neuroscience. 2024;538:1-10.
    PubMed         Abstract available

    PLoS One

  54. BELLIO TA, Laguna-Torres JY, Campion MS, Chou J, et al
    Perinatal choline supplementation prevents learning and memory deficits and reduces brain amyloid Abeta42 deposition in AppNL-G-F Alzheimer's disease model mice.
    PLoS One. 2024;19:e0297289.
    PubMed         Abstract available

  55. PAPAZOGLOU A, Henseler C, Weickhardt S, Teipelke J, et al
    Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer's disease mice.
    PLoS One. 2024;19:e0296959.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.